Investor Events Investor Events Upcoming Events There are currently no events to display. Past Events Dec 5, 2019 at 11:00 AM EST Piper Jaffray 31st Annual Healthcare Conference Click here for webcast Oct 31 - Nov 2, 2019 North American Cystic Fibrosis Conference (NACFC) - Nashville Music City Center, Nashville, TN Supporting Materials Dr. Patrick Flume presents Evaluation of Novel CFTR Modulator Combinations Of Corrector PTI-801, Potentiator PTI-808, And Amplifier PTI-428 In CF Subjects 848.9 KB Dr. Patrick Flume presents Current Status of the Proteostasis Therapeutics CFTR Modulator Development Program 2.5 MB Initial Results Evaluating the First in Class CFTR Amplifier, PTI-428, in Subjects with CF on Background Treatment with Tezacaftor/Ivacaftor 194.7 KB Evaluation of Novel CFTR Modulator Combinations of the Corrector PTI-801, Potentiator PTI-808, and Amplifier PTI-428 in CF Subjects 216.2 KB Novel Amplifier-Enhanced High-Throughput Screen for G542X-CFTR PTC Suppression Identifies Translational Read-Through Modulators with Different Profiles 245.1 KB Oct 28, 2019 at 8:00 AM EDT Cystic Fibrosis Summit – Worlds Apart: Bridging Global Disparity in CF Treatment Click here for webcast Oct 3, 2019 at 8:55 AM EDT 2019 Cantor Global Healthcare Conference Click here for webcast Sep 26, 2019 at 10:40 AM BST UK Cystic Fibrosis Conference (UKCFC) - London, England Click here for webcast Aug 6, 2019 Australasian Cystic Fibrosis Conference - Perth, Australia Supporting Materials Dr. Jane Davies Presents Novel CFTR Modulator Combinations: Evaluation of the Corrector PTI-801, Potentiator PTI-808, And Amplifier PTI-428 in CF Subjects at the 13th Australasian Cystic Fibrosis Conference in Perth, Australia, August 3-6, 2019 1 MB Jun 5, 2019 at 4:00 PM BST 42nd European Cystic Fibrosis Society Conference Supporting Materials Dr. Damian Downey presents initial results evaluating combinations of the novel CFTR corrector PTI-801, potentiator PTI-808, and amplifier PTI-428 in CF subjects 1.3 MB Dr. Manu Jain presents initial results evaluating the add-on effect of the novel CFTR corrector PTI-801 in CF subjects 757.5 KB Proteostasis Therapeutics presents initial results evaluating the novel CFTR corrector PTI-801, potentiator PTI-808, and amplifier PTI-428 in F508del homozygous CF subjects 1.4 MB May 22, 2019 at 9:00 AM EDT 2019 RBC Capital Markets Global Healthcare Conference Click here for webcast Mar 25, 2019 at 8:00 AM EDT Proteostasis Therapeutics Corporate Update Click here for webcast Feb 27, 2019 at 1:00 PM EST SVB LEERINK Partners 8th Annual Global Healthcare Conference Pagination Current page 1 Page 2 Next page Next › Last page Last » Investor Relations Investor Overview Financial Information SEC Filings News & Events Recent News Investor Events Publications Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Stock Information Analyst Coverage Shareholder Services Investor FAQs Information Request Email Alerts Contact IR Shareholder Tools Print Page Email Alerts RSS Feeds
Investor Events Upcoming Events There are currently no events to display. Past Events Dec 5, 2019 at 11:00 AM EST Piper Jaffray 31st Annual Healthcare Conference Click here for webcast Oct 31 - Nov 2, 2019 North American Cystic Fibrosis Conference (NACFC) - Nashville Music City Center, Nashville, TN Supporting Materials Dr. Patrick Flume presents Evaluation of Novel CFTR Modulator Combinations Of Corrector PTI-801, Potentiator PTI-808, And Amplifier PTI-428 In CF Subjects 848.9 KB Dr. Patrick Flume presents Current Status of the Proteostasis Therapeutics CFTR Modulator Development Program 2.5 MB Initial Results Evaluating the First in Class CFTR Amplifier, PTI-428, in Subjects with CF on Background Treatment with Tezacaftor/Ivacaftor 194.7 KB Evaluation of Novel CFTR Modulator Combinations of the Corrector PTI-801, Potentiator PTI-808, and Amplifier PTI-428 in CF Subjects 216.2 KB Novel Amplifier-Enhanced High-Throughput Screen for G542X-CFTR PTC Suppression Identifies Translational Read-Through Modulators with Different Profiles 245.1 KB Oct 28, 2019 at 8:00 AM EDT Cystic Fibrosis Summit – Worlds Apart: Bridging Global Disparity in CF Treatment Click here for webcast Oct 3, 2019 at 8:55 AM EDT 2019 Cantor Global Healthcare Conference Click here for webcast Sep 26, 2019 at 10:40 AM BST UK Cystic Fibrosis Conference (UKCFC) - London, England Click here for webcast Aug 6, 2019 Australasian Cystic Fibrosis Conference - Perth, Australia Supporting Materials Dr. Jane Davies Presents Novel CFTR Modulator Combinations: Evaluation of the Corrector PTI-801, Potentiator PTI-808, And Amplifier PTI-428 in CF Subjects at the 13th Australasian Cystic Fibrosis Conference in Perth, Australia, August 3-6, 2019 1 MB Jun 5, 2019 at 4:00 PM BST 42nd European Cystic Fibrosis Society Conference Supporting Materials Dr. Damian Downey presents initial results evaluating combinations of the novel CFTR corrector PTI-801, potentiator PTI-808, and amplifier PTI-428 in CF subjects 1.3 MB Dr. Manu Jain presents initial results evaluating the add-on effect of the novel CFTR corrector PTI-801 in CF subjects 757.5 KB Proteostasis Therapeutics presents initial results evaluating the novel CFTR corrector PTI-801, potentiator PTI-808, and amplifier PTI-428 in F508del homozygous CF subjects 1.4 MB May 22, 2019 at 9:00 AM EDT 2019 RBC Capital Markets Global Healthcare Conference Click here for webcast Mar 25, 2019 at 8:00 AM EDT Proteostasis Therapeutics Corporate Update Click here for webcast Feb 27, 2019 at 1:00 PM EST SVB LEERINK Partners 8th Annual Global Healthcare Conference Pagination Current page 1 Page 2 Next page Next › Last page Last »
Oct 31 - Nov 2, 2019 North American Cystic Fibrosis Conference (NACFC) - Nashville Music City Center, Nashville, TN Supporting Materials Dr. Patrick Flume presents Evaluation of Novel CFTR Modulator Combinations Of Corrector PTI-801, Potentiator PTI-808, And Amplifier PTI-428 In CF Subjects 848.9 KB Dr. Patrick Flume presents Current Status of the Proteostasis Therapeutics CFTR Modulator Development Program 2.5 MB Initial Results Evaluating the First in Class CFTR Amplifier, PTI-428, in Subjects with CF on Background Treatment with Tezacaftor/Ivacaftor 194.7 KB Evaluation of Novel CFTR Modulator Combinations of the Corrector PTI-801, Potentiator PTI-808, and Amplifier PTI-428 in CF Subjects 216.2 KB Novel Amplifier-Enhanced High-Throughput Screen for G542X-CFTR PTC Suppression Identifies Translational Read-Through Modulators with Different Profiles 245.1 KB
Dr. Patrick Flume presents Evaluation of Novel CFTR Modulator Combinations Of Corrector PTI-801, Potentiator PTI-808, And Amplifier PTI-428 In CF Subjects 848.9 KB
Dr. Patrick Flume presents Current Status of the Proteostasis Therapeutics CFTR Modulator Development Program 2.5 MB
Initial Results Evaluating the First in Class CFTR Amplifier, PTI-428, in Subjects with CF on Background Treatment with Tezacaftor/Ivacaftor 194.7 KB
Evaluation of Novel CFTR Modulator Combinations of the Corrector PTI-801, Potentiator PTI-808, and Amplifier PTI-428 in CF Subjects 216.2 KB
Novel Amplifier-Enhanced High-Throughput Screen for G542X-CFTR PTC Suppression Identifies Translational Read-Through Modulators with Different Profiles 245.1 KB
Oct 28, 2019 at 8:00 AM EDT Cystic Fibrosis Summit – Worlds Apart: Bridging Global Disparity in CF Treatment Click here for webcast
Sep 26, 2019 at 10:40 AM BST UK Cystic Fibrosis Conference (UKCFC) - London, England Click here for webcast
Aug 6, 2019 Australasian Cystic Fibrosis Conference - Perth, Australia Supporting Materials Dr. Jane Davies Presents Novel CFTR Modulator Combinations: Evaluation of the Corrector PTI-801, Potentiator PTI-808, And Amplifier PTI-428 in CF Subjects at the 13th Australasian Cystic Fibrosis Conference in Perth, Australia, August 3-6, 2019 1 MB
Dr. Jane Davies Presents Novel CFTR Modulator Combinations: Evaluation of the Corrector PTI-801, Potentiator PTI-808, And Amplifier PTI-428 in CF Subjects at the 13th Australasian Cystic Fibrosis Conference in Perth, Australia, August 3-6, 2019 1 MB
Jun 5, 2019 at 4:00 PM BST 42nd European Cystic Fibrosis Society Conference Supporting Materials Dr. Damian Downey presents initial results evaluating combinations of the novel CFTR corrector PTI-801, potentiator PTI-808, and amplifier PTI-428 in CF subjects 1.3 MB Dr. Manu Jain presents initial results evaluating the add-on effect of the novel CFTR corrector PTI-801 in CF subjects 757.5 KB Proteostasis Therapeutics presents initial results evaluating the novel CFTR corrector PTI-801, potentiator PTI-808, and amplifier PTI-428 in F508del homozygous CF subjects 1.4 MB
Dr. Damian Downey presents initial results evaluating combinations of the novel CFTR corrector PTI-801, potentiator PTI-808, and amplifier PTI-428 in CF subjects 1.3 MB
Dr. Manu Jain presents initial results evaluating the add-on effect of the novel CFTR corrector PTI-801 in CF subjects 757.5 KB
Proteostasis Therapeutics presents initial results evaluating the novel CFTR corrector PTI-801, potentiator PTI-808, and amplifier PTI-428 in F508del homozygous CF subjects 1.4 MB
May 22, 2019 at 9:00 AM EDT 2019 RBC Capital Markets Global Healthcare Conference Click here for webcast
